Therefore, we not only illustrated that epigenetic regulation axis HDAC/OAZ1 are responsible for cisplatin resistance in NSCLC but also provided a feasible therapeutic approach against cisplatin resistance. Here, OAZ1 is linked to non-small cell lung carcinoma.